Ra Capital Management, L.P. Concert Pharmaceuticals, Inc. Put Options Transaction History
Ra Capital Management, L.P.
- $7.17 Billion
- Q3 2024
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding CNCE
# of Institutions
1Shares Held
0Call Options Held
0Put Options Held
0About CONCERT PHARMACEUTICALS, INC.
- Ticker CNCE
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 47,934,600
- Description
- Concert Pharmaceuticals, Inc. operates as a clinical stage biopharmaceutical company that develops novel small molecule drugs for the treatment of autoimmune diseases. The company's lead product candidate is CTP-543, which is in Phase III clinical trial for the treatment of alopecia areata, a serious autoimmune dermatological condition. It has s...